Alimera Sciences Inc. (ALIM)
Alimera Sciences Statistics
Share Statistics
Alimera Sciences has 54.38M shares outstanding. The number of shares has increased by 3.81% in one year.
| Shares Outstanding | 54.38M |
| Shares Change (YoY) | 3.81% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 85.26% |
| Shares Floating | 13.18M |
| Failed to Deliver (FTD) Shares | 3.4M |
| FTD / Avg. Volume | 375.27% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is null and the forward PE ratio is null.
| PE Ratio | null |
| Forward PE | n/a |
| PS Ratio | 1.37 |
| Forward PS | null |
| PB Ratio | 2.39 |
| P/FCF Ratio | null |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Alimera Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of null.
| Current Ratio | 2.39 |
| Quick Ratio | 2.31 |
| Debt / Equity | null |
| Debt / EBITDA | 9.26 |
| Debt / FCF | -0.75 |
| Interest Coverage | null |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $524.38K |
| Profits Per Employee | $-130.73K |
| Employee Count | 154 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 10.42 |
Taxes
| Income Tax | 85K |
| Effective Tax Rate | -0.42% |
Stock Price Statistics
The stock price has increased by 65.87% in the last 52 weeks. The beta is 1.25, so Alimera Sciences's price volatility has been higher than the market average.
| Beta | 1.25 |
| 52-Week Price Change | 65.87% |
| 50-Day Moving Average | 5.56 |
| 200-Day Moving Average | 4.21 |
| Relative Strength Index (RSI) | 52.49 |
| Average Volume (20 Days) | 907.26K |
Income Statement
In the last 12 months, Alimera Sciences had revenue of 80.75M and earned -20.13M in profits. Earnings per share was -0.79.
| Revenue | 80.75M |
| Gross Profit | 61.17M |
| Operating Income | -1.47M |
| Net Income | -20.13M |
| EBITDA | 7.28M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.79 |
Balance Sheet
The company has 12.09M in cash and 67.4M in debt, giving a net cash position of -55.31M.
| Cash & Cash Equivalents | 12.09M |
| Total Debt | 67.4M |
| Net Cash | -55.31M |
| Retained Earnings | -418.49M |
| Total Assets | 150.38M |
| Working Capital | 35.57M |
Cash Flow
In the last 12 months, operating cash flow was -14.26M and capital expenditures -75.53M, giving a free cash flow of -89.79M.
| Operating Cash Flow | -14.26M |
| Capital Expenditures | -75.53M |
| Free Cash Flow | -89.79M |
| FCF Per Share | -3.51 |
Margins
Gross margin is 75.75%, with operating and profit margins of -1.82% and -24.93%.
| Gross Margin | 75.75% |
| Operating Margin | -1.82% |
| Pretax Margin | -24.82% |
| Profit Margin | -24.93% |
| EBITDA Margin | n/a |
| EBIT Margin | -1.82% |
| FCF Margin | -111.19% |
Dividends & Yields
ALIM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ALIM is $6, which is 8.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $6 |
| Price Target Difference | 8.3% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Nov 15, 2019. It was a backward split with a ratio of 1:15.
| Last Split Date | Nov 15, 2019 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -1.65 |
| Piotroski F-Score | 1 |